Medical literature from PubMed.
Localized medical information briefs for every market.
Field medical teams in every market need the same evidence synthesis — not an English summary forwarded with a request to translate it. Claude retrieves relevant publications from PubMed via MCP, and Lara Translate delivers a localized medical information brief to each market team with your medical terminology enforced.
No credit card required
No credit card required
From PubMed literature to localized medical information briefs for every market team.
Claude queries PubMed via MCP and retrieves peer-reviewed publications relevant to the mechanism of action, pharmacokinetic data, and safety signals for the compound. The medical information brief is structured for field team use. Lara Translate localizes the output with your medical affairs glossary enforced, producing a brief for each market team.
Ask Claude to retrieve the relevant literature from PubMed
Claude connects to PubMed via MCP and retrieves peer-reviewed publications matching the specified scientific question, target mechanism, compound class, population, and publication timeframe. It returns full abstracts with study design, key findings, and pharmacokinetic or pharmacodynamic parameters.
PubMed returns 6 publications with mechanistic and safety data
PubMed returns all 6 publications with mechanistic findings, pharmacokinetic parameters, and safety signal data. Claude structures the extracted information into a medical information brief organized by scientific domain, mechanism, pharmacokinetics, and safety, with study context noted for each finding.
Lara Translate localizes the brief for the Japan medical affairs team
Lara Translate localizes the medical information brief into Japanese using Faithful style, scientific terminology preserved exactly, pharmacokinetic parameters and safety incidence rates treated as non-translatable units. The medical affairs glossary enforces approved Japanese translations for mechanistic descriptors and pharmacological terms consistent with Japanese pharmaceutical standards.
The Japan field medical team receives a complete Japanese medical brief
The Japan medical affairs team receives a structured Japanese document: mechanistic findings from 3 studies with study context, pharmacokinetic parameters from the most recent publications, and emerging safety signals with incidence data. The brief is ready for field medical discussions, with scientific terminology the Japan team recognizes from domestic pharmaceutical documentation.
Why field medical teams reading English PubMed abstracts creates scientific exchange risk
A field medical professional engaging with healthcare providers in Japanese about mechanistic data published in English is working from a real-time mental translation, which introduces approximation risk for pharmacokinetic parameters, safety characterizations, and mechanistic descriptors that have specific approved equivalents in Japanese pharmaceutical documentation. Lara Translate applied via Claude MCP produces a medical information brief in Japanese with the approved scientific vocabulary for that market, so the field medical team references the same parameters and descriptions in scientific exchange that appear in domestic pharmaceutical documentation.
What makes a localized medical information brief reliable for a field team.
A medical information brief with paraphrased mechanism data or inconsistent medical terminology creates field communication risk. These four properties prevent that.
Medical and scientific terminology consistent across every market
Drug names, mechanism terminology, and pharmacological vocabulary stay consistent across every localized medical information brief. Translation memory reuses your approved medical affairs phrasing.
Faithful style for all scientific content
Faithful translation preserves mechanism of action descriptions, pharmacokinetic data, and safety signals exactly. No paraphrase — every scientific statement means what the publication said.
Scientific evidence and clinical context preserved exactly
A specific mechanism of action or safety signal carries precise medical meaning. You pass the domain and field team context, and Lara Translate localizes accordingly.
Localized medical information briefs for every market team in one session
In any of 203 languages. Every field team communicates from the same evidence base.
Claude + PubMed vs.
Claude + PubMed + Lara Translate
| What you need | Claude + PubMed | Claude + PubMed + Lara Translate |
|---|---|---|
| Scientific terms matching approved local pharma vocabulary | No controlled vocabulary. MeSH terms and clinical terminology may be rendered inconsistently. | Medical affairs glossary aligns terms with local pharma docs |
| PK parameters and safety data preserved, no approximation | No style mode. Patient-facing summaries and peer-review abstracts get the same generic treatment. | Faithful style. PK and safety data preserved as reported |
| Study context preserved with every finding | P-values, dosage data, and statistics may be paraphrased rather than preserved verbatim. | Claude extracts findings with full study context intact |
| Literature retrieved and structured in one session | Each PubMed abstract requires manual processing per language. | Claude retrieves, structures, and localizes in one conversation |
| All global medical teams from the same literature in one session | No translation memory. Repeated clinical terms are not aligned across studies or reviews. | 200 languages, same session, same medical affairs glossary |
Ready to brief every global medical affairs team from the same published evidence?
One PubMed query. A structured, localized medical information brief for every market in under 4 minutes.
No credit card required
No credit card required
Build your multilingual AI workflow with us
Tell us your stack and what you want to ship. We'll help you wire your AI assistant to the right tools and Lara Translate so the output lands in every language your team works in — terminology enforced, tone matched.